Mrs Aimee Jackson

Institute of Cancer and Genomic Sciences
Principal Biostatistician

Contact details

Address
Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Aimee Jackson is a Principal Biostatistician at Cancer Research UK Clinical Trials Unit (CRCTU). She joined CRCTU in 2013 and specialises in haematological cancers. Her research focuses on efficient designs and the use of Bayesian methodology.

Qualifications

  • MSc in Biometry, University of Reading, 2012
  • BSc (Hons) in Applied Statistics, University of Plymouth, 2011 

Biography

Aimee Joined the CRCTU a year after completing her MSc in Biometry at the University of Reading and is now a Principal Biostatistician within the unit. Aimee takes statistical lead of haematology oncology portfolios within CRCTU including paediatric haematology oncology trials, adult haematology trials and stem cell transplant trials. She has experience in all trial phases from dose finding studies to phase III studies and is involved in the design, supervision, analysis, and reporting of trials.

Aimee’s research focus is the application of efficient trial designs in both a Bayesian and frequentist framework, including the use of adaptive trial designs, platform trial and trials with multiple randomisation or questions. 

Teaching

MSc Clinical Trials, Co-module lead for Design and delivery of further clinical trials module

Other activities

Aimee is part of the Blood Cancer UK Clinical Trials Review Committee. She sits on external data monitoring committees for trials at other units and is part of the NCRI Myelodysplastic syndromes (MDS) sub group committee.